Article
Metabolic syndrome as a modifier of atherosclerosis in murine models.
Current drug targets - 1 Nov 2007
Péterfy Miklós, Davis Richard C, Lusis Aldons J
Abstract excerpt
The Metabolic Syndrome is a common metabolic disease associated with an increased risk for atherosclerotic cardiovascular disease and mortality. In contrast to "traditional" risk factors for atherosclerosis, such as low-density lipoprotein cholesterol, the Metabolic Syndrome represents a network of interacting risk factors stemming from the metabolic complexity of this disease. For this reason, dissection of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
